Patent & Trade Mark
Attorneys
We are
Experts in Navigating IP in the Asia Pacific Region
Working with clients in
Thanks to many years of global experience, FB Rice has a network of trusted advisors in all key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.
John Landells

Partner

John Landells
“Changes to New Zealand’s patent law and practice in 2014 has brought New Zealand more into alignment with Australia, significantly raising the threshold for patentability in New Zealand. Most of our attorneys are registered to represent our clients in both Australia and New Zealand, which ensures that our clients get the best protection of their assets across both jurisdictions.”
“Changes to New Zealand’s patent law and practice in 2014 has brought New Zealand more into alignment with Australia, significantly raising the threshold for patentability in New Zealand. Most of our attorneys are registered to represent our clients in both Australia and New Zealand, which ensures that our clients get the best protection of their assets across both jurisdictions.”
Working Requirement in Indonesia
As the largest economy in South-East Asia, Indonesia is an attractive and valuable jurisdiction for patent protection. While Indonesia has largely been a major importer of manufactured goods and technical skills, the economy of Indonesia has recently shifted towards manufacturing and trade. Accordingly, the Indonesian government is keen to promote technology transfer and encourage local job opportunities and has introduced a working requirement for Indonesian patents and has recently further clarified the process.
As the largest economy in South-East Asia, Indonesia is an attractive and valuable jurisdiction for patent protection. While Indonesia has largely been a major importer of manufactured goods and technical skills, the economy of Indonesia has recently shifted towards manufacturing and trade. Accordingly, the Indonesian government is keen to promote technology transfer and encourage local job opportunities and has introduced a working requirement for Indonesian patents and has recently further clarified the process.
29 March 2018
Did you say ‘a shortage of cocoa beans’?
The thought of the cocoa bean extinction on the horizon due to climate change gives me the shivers. Without cocoa beans, there is no chocolate! Don’t panic; science and innovation is working towards future-proofing the chocolate industry.
The thought of the cocoa bean extinction on the horizon due to climate change gives me the shivers. Without cocoa beans, there is no chocolate! Don’t panic; science and innovation is working towards future-proofing the chocolate industry.
Lisa Neilson

Associate

Lisa Neilson
Lisa is a Trade Marks Associate in our Sydney office and joined the firm in 2009. Lisa’s practice covers all aspects of trade mark registration, protection and enforcement in Australia and New Zealand including prosecution, oppositions and non-use removal actions.
Lisa is a Trade Marks Associate in our Sydney office and joined the firm in 2009. Lisa’s practice covers all aspects of trade mark registration, protection and enforcement in Australia and New Zealand including prosecution, oppositions and non-use removal actions.
10 December 2018
FB Rice office closure dates
Our offices will be closed on 25 and 26 December 2018, and from 29 December 2018 to 1 January 2019.
Our offices will be closed on 25 and 26 December 2018, and from 29 December 2018 to 1 January 2019.
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.